The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Circulating Tumor Cells-Global Market Insights and Sales Trends 2025
Synopsis
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The global Circulating Tumor Cells market size is expected to reach US$ 5895.4 million by 2029, growing at a CAGR of 20.4% from 2023 to 2029. The market is mainly driven by the significant applications of Circulating Tumor Cells in various end use industries. The expanding demands from the Breast Cancer, Prostate Cancer, Colorectal Cancer and Lung Cancer, are propelling Circulating Tumor Cells market. CTC Enrichment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CTC Detection segment is estimated at % CAGR for the next seven-year period.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Circulating Tumor Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Circulating Tumor Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Circulating Tumor Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Circulating Tumor Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Circulating Tumor Cells covered in this report include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech and Fluxion Biosciences, etc.
The global Circulating Tumor Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Global Circulating Tumor Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Circulating Tumor Cells market, Segment by Type:
CTC Enrichment
CTC Detection
CTC Analysis
Global Circulating Tumor Cells market, by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Circulating Tumor Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The global Circulating Tumor Cells market size is expected to reach US$ 5895.4 million by 2029, growing at a CAGR of 20.4% from 2023 to 2029. The market is mainly driven by the significant applications of Circulating Tumor Cells in various end use industries. The expanding demands from the Breast Cancer, Prostate Cancer, Colorectal Cancer and Lung Cancer, are propelling Circulating Tumor Cells market. CTC Enrichment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CTC Detection segment is estimated at % CAGR for the next seven-year period.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Circulating Tumor Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Circulating Tumor Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Circulating Tumor Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Circulating Tumor Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Circulating Tumor Cells covered in this report include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech and Fluxion Biosciences, etc.
The global Circulating Tumor Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Global Circulating Tumor Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Circulating Tumor Cells market, Segment by Type:
CTC Enrichment
CTC Detection
CTC Analysis
Global Circulating Tumor Cells market, by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Circulating Tumor Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Circulating Tumor Cells
1.1 Circulating Tumor Cells Market Overview
1.1.1 Circulating Tumor Cells Product Scope
1.1.2 Circulating Tumor Cells Market Status and Outlook
1.2 Global Circulating Tumor Cells Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Circulating Tumor Cells Market Size by Region (2018-2029)
1.4 Global Circulating Tumor Cells Historic Market Size by Region (2018-2023)
1.5 Global Circulating Tumor Cells Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Circulating Tumor Cells Market Size (2018-2029)
1.6.1 North America Circulating Tumor Cells Market Size (2018-2029)
1.6.2 Europe Circulating Tumor Cells Market Size (2018-2029)
1.6.3 Asia-Pacific Circulating Tumor Cells Market Size (2018-2029)
1.6.4 Latin America Circulating Tumor Cells Market Size (2018-2029)
1.6.5 Middle East & Africa Circulating Tumor Cells Market Size (2018-2029)
2 Circulating Tumor Cells Market by Type
2.1 Introduction
2.1.1 CTC Enrichment
2.1.2 CTC Detection
2.1.3 CTC Analysis
2.2 Global Circulating Tumor Cells Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Circulating Tumor Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Circulating Tumor Cells Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Circulating Tumor Cells Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Circulating Tumor Cells Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Circulating Tumor Cells Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Circulating Tumor Cells Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Circulating Tumor Cells Revenue Breakdown by Type (2018-2029)
3 Circulating Tumor Cells Market Overview by Application
3.1 Introduction
3.1.1 Breast Cancer
3.1.2 Prostate Cancer
3.1.3 Colorectal Cancer
3.1.4 Lung Cancer
3.1.5 Others
3.2 Global Circulating Tumor Cells Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Circulating Tumor Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Circulating Tumor Cells Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Circulating Tumor Cells Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Circulating Tumor Cells Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Circulating Tumor Cells Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Circulating Tumor Cells Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Circulating Tumor Cells Revenue Breakdown by Application (2018-2029)
4 Circulating Tumor Cells Competition Analysis by Players
4.1 Global Circulating Tumor Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2022)
4.3 Date of Key Players Enter into Circulating Tumor Cells Market
4.4 Global Top Players Circulating Tumor Cells Headquarters and Area Served
4.5 Key Players Circulating Tumor Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Circulating Tumor Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Menarini-Silicon Biosystems
5.1.1 Menarini-Silicon Biosystems Profile
5.1.2 Menarini-Silicon Biosystems Main Business
5.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Products, Services and Solutions
5.1.4 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Menarini-Silicon Biosystems Recent Developments
5.2 Qiagen (Adnagen)
5.2.1 Qiagen (Adnagen) Profile
5.2.2 Qiagen (Adnagen) Main Business
5.2.3 Qiagen (Adnagen) Circulating Tumor Cells Products, Services and Solutions
5.2.4 Qiagen (Adnagen) Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.2.5 Qiagen (Adnagen) Recent Developments
5.3 Advanced Cell Diagnostics
5.3.1 Advanced Cell Diagnostics Profile
5.3.2 Advanced Cell Diagnostics Main Business
5.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Products, Services and Solutions
5.3.4 Advanced Cell Diagnostics Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.3.5 ApoCell Recent Developments
5.4 ApoCell
5.4.1 ApoCell Profile
5.4.2 ApoCell Main Business
5.4.3 ApoCell Circulating Tumor Cells Products, Services and Solutions
5.4.4 ApoCell Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.4.5 ApoCell Recent Developments
5.5 Epic Sciences
5.5.1 Epic Sciences Profile
5.5.2 Epic Sciences Main Business
5.5.3 Epic Sciences Circulating Tumor Cells Products, Services and Solutions
5.5.4 Epic Sciences Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.5.5 Epic Sciences Recent Developments
5.6 Greiner Bio-one GmbH
5.6.1 Greiner Bio-one GmbH Profile
5.6.2 Greiner Bio-one GmbH Main Business
5.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Products, Services and Solutions
5.6.4 Greiner Bio-one GmbH Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.6.5 Greiner Bio-one GmbH Recent Developments
5.7 Cynvenio
5.7.1 Cynvenio Profile
5.7.2 Cynvenio Main Business
5.7.3 Cynvenio Circulating Tumor Cells Products, Services and Solutions
5.7.4 Cynvenio Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.7.5 Cynvenio Recent Developments
5.8 SurExamBio-Tech
5.8.1 SurExamBio-Tech Profile
5.8.2 SurExamBio-Tech Main Business
5.8.3 SurExamBio-Tech Circulating Tumor Cells Products, Services and Solutions
5.8.4 SurExamBio-Tech Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.8.5 SurExamBio-Tech Recent Developments
5.9 Fluxion Biosciences
5.9.1 Fluxion Biosciences Profile
5.9.2 Fluxion Biosciences Main Business
5.9.3 Fluxion Biosciences Circulating Tumor Cells Products, Services and Solutions
5.9.4 Fluxion Biosciences Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.9.5 Fluxion Biosciences Recent Developments
5.10 Ikonisys
5.10.1 Ikonisys Profile
5.10.2 Ikonisys Main Business
5.10.3 Ikonisys Circulating Tumor Cells Products, Services and Solutions
5.10.4 Ikonisys Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.10.5 Ikonisys Recent Developments
5.11 Hangzhou Watson Biotech
5.11.1 Hangzhou Watson Biotech Profile
5.11.2 Hangzhou Watson Biotech Main Business
5.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Products, Services and Solutions
5.11.4 Hangzhou Watson Biotech Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.11.5 Hangzhou Watson Biotech Recent Developments
5.12 Biocept
5.12.1 Biocept Profile
5.12.2 Biocept Main Business
5.12.3 Biocept Circulating Tumor Cells Products, Services and Solutions
5.12.4 Biocept Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.12.5 Biocept Recent Developments
5.13 CytoTrack
5.13.1 CytoTrack Profile
5.13.2 CytoTrack Main Business
5.13.3 CytoTrack Circulating Tumor Cells Products, Services and Solutions
5.13.4 CytoTrack Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.13.5 CytoTrack Recent Developments
5.14 Guangzhou Wondfo Biotech
5.14.1 Guangzhou Wondfo Biotech Profile
5.14.2 Guangzhou Wondfo Biotech Main Business
5.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Products, Services and Solutions
5.14.4 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.14.5 Guangzhou Wondfo Biotech Recent Developments
5.15 Celsee
5.15.1 Celsee Profile
5.15.2 Celsee Main Business
5.15.3 Celsee Circulating Tumor Cells Products, Services and Solutions
5.15.4 Celsee Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.15.5 Celsee Recent Developments
5.16 Clearbridge Biomedics
5.16.1 Clearbridge Biomedics Profile
5.16.2 Clearbridge Biomedics Main Business
5.16.3 Clearbridge Biomedics Circulating Tumor Cells Products, Services and Solutions
5.16.4 Clearbridge Biomedics Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.16.5 Clearbridge Biomedics Recent Developments
5.17 ANGLE plc
5.17.1 ANGLE plc Profile
5.17.2 ANGLE plc Main Business
5.17.3 ANGLE plc Circulating Tumor Cells Products, Services and Solutions
5.17.4 ANGLE plc Circulating Tumor Cells Revenue (US$ Million) & (2018-2023)
5.17.5 ANGLE plc Recent Developments
6 North America
6.1 North America Circulating Tumor Cells Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Circulating Tumor Cells Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Circulating Tumor Cells Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Circulating Tumor Cells Market Dynamics
11.1 Circulating Tumor Cells Industry Trends
11.2 Circulating Tumor Cells Market Drivers
11.3 Circulating Tumor Cells Market Challenges
11.4 Circulating Tumor Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
